Bhaskar Narayan Thorat

Bhaskar Narayan Thorat

Active Director Director DIN 01293824
DIN 01293824 First appointment Jul 2005 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 2 historical roles
Total affiliations 3 Since Jul 2005
Shareholding value •••• Premium profile

About Bhaskar Narayan Thorat

Data last updated:

Bhaskar Narayan Thorat is a Director at Aarti Drugs Limited (since 2022). The companies operate in Chemicals and Materials. Aarti Drugs Limited reported revenue of ₹2,403 Cr (FY 2025). Earlier, Bhaskar Narayan Thorat was an Additional Director at Spanol Chemicals Private Limited (2005–2015) and Managing Director at Wfcfd Advanced Techno-Services Private Limited (from 2011).

DIN 01293824
Primary Designation Director
Industry Chemicals and Materials
First Appointment 23 Jul 2005
Oldest Company Age 42 yrs
Largest company Aarti Drugs Limited · ₹2,403 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aarti Drugs Limited L37060MH1984PLC055433
Director09 May 20221984₹2,403 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Spanol Chemicals Private Limited U24117MH2000PTC129916
Additional Director23 Jul 20052000₹7.3 Lakh (FY 2020)Active
Managing Director03 Aug 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Bhaskar Narayan Thorat

NameDINCompanyDesignation
Adhish Prakash PatilAarti Drugs LimitedCfo
Ajit Eledath Venugopalan09439069Aarti Drugs LimitedDirector
Ankit Vikram Paleja06975564Aarti Drugs LimitedDirector
Harit Pragji Shah00005501Aarti Drugs LimitedWhole-Time Director
Harshit Manilal Savla00005340Aarti Drugs LimitedManaging Director
Hasmukh Bhavanji Dedhia07510925Aarti Drugs LimitedDirector
Narendra Jagannath Salvi00299202Aarti Drugs LimitedDirector
Neha Rajen Gada01642373Aarti Drugs LimitedDirector
Prakash Moreshwar Patil00005618Aarti Drugs LimitedManaging Director
Prakash Moreshwar PatilAarti Drugs LimitedCeo
Rashesh Chandrakant Gogri00066291Aarti Drugs LimitedManaging Director
Rushikesh Vivek DeoleAarti Drugs LimitedCompany Secretary
Sandeep Madhusudan Joshi00516409Aarti Drugs LimitedDirector
Uday Moreshwar Patil01186406Aarti Drugs LimitedWhole-Time Director

Directorship timeline

Open interactive timeline →
Wfcfd Advanced Techno-Services Private Limited
Aarti Drugs Limited
Spanol Chemicals Private Limited
Premium access

Shareholding and investment profile for Bhaskar Narayan Thorat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhaskar Narayan Thorat

Bhaskar Narayan Thorat currently holds 1 directorship: Aarti Drugs Limited (Director, since 09 May 2022, revenue ₹2,403 Cr (FY 2025)).

Bhaskar Narayan Thorat was first appointed on 23 Jul 2005 as Additional Director at Spanol Chemicals Private Limited. The most recent appointment on record is 09 May 2022 at Aarti Drugs Limited.

Bhaskar Narayan Thorat held 2 earlier board appointments: Spanol Chemicals Private Limited (Additional Director, 23 Jul 2005 to 15 May 2015); Wfcfd Advanced Techno-Services Private Limited (Managing Director, from 03 Aug 2011).

The current boards of Bhaskar Narayan Thorat's companies include Adhish Prakash Patil (Aarti Drugs Limited), Ajit Eledath Venugopalan (Aarti Drugs Limited), Ankit Vikram Paleja (Aarti Drugs Limited), Harit Pragji Shah (Aarti Drugs Limited), Harshit Manilal Savla (Aarti Drugs Limited), Hasmukh Bhavanji Dedhia (Aarti Drugs Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available